Updated · Psiconáutica Editorial Team
Psychedelics Guide › Ketamine and Dissociatives: What They Are, Uses, and Risks
Ketamine and other dissociatives belong to a family of substances that share a fundamental mechanism: they act on glutamate NMDA receptors to produce a state of apparent “disconnection” between the mind, the body, and the environment, known as dissociative anesthesia. Alongside ketamine and its derivative esketamine, this group includes phencyclidine (PCP), dextromethorphan (DXM), and nitrous oxide.
These are multifaceted substances. Ketamine is a standard anesthetic and analgesic in human and veterinary medicine, and intranasal esketamine is used for treatment-resistant depression in a clinical setting. At the same time, they are part of psychonaut culture and recreational use, with effects ranging from the introspective to the profoundly strange. Many of their possible applications are still under investigation, and enthusiasm and alarmism both deserve to be read with the same calm.
This guide gathers—from a perspective of harm reduction and respect for individual autonomy—what is currently known about ketamine and dissociatives: what they are, how they act, what they are used for in medicine, and what precautions help in exploring them more sensibly. We start from a simple idea: free information is the best tool for making decisions. You will not find sermons or miraculous promises here, but an honest reading of a field full of nuances, myths, and open questions.
Featured reading
- Ketamine: Between Anesthesia and Neuronal Regeneration
- A Rigorous Trial Questions the Efficacy of Ketamine for Depression
- Synthesis of 4-methoxy PCP
Recent Studies and Evidence
What the latest clinical research (Nature, JAMA, NEJM, Lancet, PubMed) shows, told with rigor and without exaggeration.
Essential Guides
Our educational guides on this topic, with verified sources and a harm reduction approach.
- What Is Ketamine: Pharmacology, Effects, and Medical Uses
- Ketamine and Resistant Depression: What the Clinical Evidence Says
- Esketamine (Spravato): The Approved Antidepressant and How It Works
- Risks of Ketamine: Cystitis, Dependence, and the “K-Hole”
- Recreational vs. Clinical Ketamine: Uses and Harm Reduction
- History of Ketamine: From the Operating Room to Psychiatry
What Is Ketamine: Pharmacology and Dissociative Anesthesia
Ketamine is an anesthetic and analgesic that acts as an antagonist to glutamate NMDA receptors, producing what is called dissociative anesthesia. Here we explain what it is, how it alters perception, memory, and the sense of the body, and why it is grouped among dissociatives.
Ketamine and Esketamine in Mental Health: Depression and Evidence
Intranasal esketamine is authorized for treatment-resistant depression in supervised clinical settings, but the evidence regarding its efficacy remains debated. We gather what the trials show, including the most critical and cautious readings.
Chemistry of Arylcyclohexylamines (Technical and Historical Archive)
Technical and historical archive material on the chemistry of arylcyclohexylamines related to phencyclidine (PCP). It is collected for strictly documentary purposes; it does not constitute a guide for use or the manufacturing of substances.
- Synthesis of 4-methoxy PCP
Frequently Asked Questions
What is ketamine and why is it called a “dissociative” drug?
Ketamine is an anesthetic and analgesic drug that acts by blocking glutamate NMDA receptors in the brain. At certain doses, it produces a state in which the person feels “disconnected” from their body and environment, known as dissociative anesthesia. Because of this effect, it is grouped with other dissociatives like PCP, DXM, and nitrous oxide.
Is ketamine used to treat depression?
Intranasal esketamine (a derivative of ketamine) is authorized by European, American, and Spanish regulatory agencies for treatment-resistant depression, administered in a clinical setting and combined with other antidepressants. In some patients, it offers rapid relief, although the evidence remains under discussion and there are rigorous trials that temper claims of its efficacy relative to placebo. This is a supervised clinical use, distinct from self-administration.
What is the difference between ketamine and esketamine?
Conventional ketamine is a mixture of two mirror-image forms of the same molecule (the R and S enantiomers). Esketamine is only the S-form, isolated and developed as an intranasal medication for resistant depression. They are not exactly the same: potency, route of administration, and the setting in which each is used all differ.
What are the risks of recreational ketamine use?
Repeated use at high doses has been associated with damage to the bladder and urinary tract (so-called ketamine-induced cystitis), which can be serious in advanced cases, as well as potential cognitive impairment, dependence, and accidents linked to the state of dissociation. Combining it with alcohol or other depressants multiplies the risk. From a harm reduction perspective, the best protection is knowing these limits, paying attention to dose, setting, and mixtures, and having trusted company.
What other substances are considered dissociative?
In addition to ketamine and esketamine, this category usually includes phencyclidine (PCP), dextromethorphan (DXM), found in some cough syrups, when taken far above the usual dose; nitrous oxide or “laughing gas,” and analogs like MXE. They share the trait of acting on the glutamate system and altering perception, although their profiles, availability, and risks differ.
Is ketamine legal in Spain?
In Spain, ketamine is a medication for hospital and veterinary use, and esketamine is authorized for resistant depression within a specific clinical framework; outside a medical prescription, no legal use is provided for. That is simply the regulatory fact, and it says nothing about its pharmacological or cultural interest. This information is educational and does not constitute legal or medical advice.
What is ketamine and what is it used for?
Ketamine is a dissociative anesthetic synthesized in 1962 and in clinical use ever since. It is on the WHO Model List of Essential Medicines, mainly because it maintains breathing and blood pressure better than other anesthetics, which makes it especially useful where resuscitation equipment is not on hand.
Today it has three clearly distinct uses, and it is best not to mix them up:
- Anesthesia and analgesia: its original use, in the operating room and emergency departments.
- Resistant depression: in much lower doses and under medical supervision. Esketamine, one of its two enantiomers, is marketed as Spravato for this indication.
- Recreational use: for its dissociative effects, which at high doses produce the state known as the K-hole.
Its effects appear quickly and last a short time—between forty minutes and an hour when taken intranasally—which makes it easy to misjudge how much has been taken. Its most characteristic risk is not acute but cumulative: bladder damage associated with frequent and prolonged use, which can become irreversible and is discussed far less than it should be.
